Feinstein Institute-led researchers used an Alzheimer’s drug to reduce inflammation in people with metabolic syndrome.
Targeting a cell process that promotes protein clumping could lead to new drugs for ALS.
With pressures to fast-track clinical development, the pharmaceutical industry recognizes the value of improving internal clinical data management processes.…
This past week ushered in new discoveries in flu prevention, pancreatic cancer and HIV.
Penn scientists discovered three genetic variants that may help the immune system fight Alzheimer’s—and that may be targetable with drugs.
A pair of experimental vaccines protected mouse fetuses from brain defects caused by Zika infection.
Anti-CRISPR proteins may be the key to preventing harmful side effects from off-target editing.
M.D. Anderson Cancer Center researchers are developing a CAR-T alternative derived from umbilical cord blood.
Researchers at Washington University have discovered a new way to shield fetuses from Zika using a common and inexpensive malaria drug.
A team led by Washington University in St. Louis has unraveled the structure of a protein that allows RSV to elude the immune system.
York University scientists have found that beta blockers could potentially reverse heart failure.